Answers - Finance

Life Settlements, also commonly referred to, as Life Insurance Settlements are quickly beco

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ming an exciting financial planning tool for seniors and the financial advisors who assist

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

hese seniors.

The initial process before determining if a settlement is available is meeti

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

g a few of the basic requirements. The types of insurance policies that can be considered f

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

r a life settlement are universal life, whole life, variable life, survivorship (any type),

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

adjustable life, joint first to die, and term insurance (if convertible). It is also common

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

practice for the insured to be over the age of 65.

The process begins with when the indivi

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

dual policyholder "cases" are submitted to a Life Settlement Broker or Company through a co

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

pleted application and a HIPPA release form.

Policyholders will provide a current policy i

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

lustration, medical records, for the insured, as well as other documents that may be reques

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ed.

After a completed thorough evaluation of the policy, a potential life settlement value

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

is determined for each individual case submitted. This evaluation includes a review of subm

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

tted medical records by an independent medical underwrite. A medical exam or physical is NO

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

required.

If the funding source is interested in purchasing the policy, an offer to purch

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ase the policy is communicated to the policyholder's broker or financial advisor (Not all p

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

licies will qualify for a life settlement).

If the offer is accepted, closing documents ar

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

prepared and sent to the policy owner through their life settlement professional.

It is t

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

e policyholders chose if the want to accept or decline the offer. There is never any cost o

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

obligation during the initial life settlement process. The settlement offer is determined

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

n a case-by-case basis and evaluation of the policy is required before an offer can be made

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/118356/answers-The-Life-Settlement--Process.html">The Life Settlement Process</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/118356/answers-The-Life-Settlement--Process.html]The Life Settlement Process[/url]

Apart from the major downside of the Yellow Pages that it is nipplepiercingly expensive, it is still a bottomachingly brilliant vehicle to take your marketing message to your target audience. Well, some people think, the YP is on its way out, and I totally agree, but I believe it has a few more years of marching to do until it completely vanishes into thin air or even into a puff of smoke.

Your marketing sure could do with this X factor. The psychology of humans is based partly on something for nothing. Find out how you can use this to your advantage! And, How can you apply this simple marketing strategy and psychological principle to rake in some big bucks?

Tags

Links

Answers - The Life Settlement Process

Related Articles: